Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rhys Whomsley

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Drug Discovery Today|August 21, 2007
Drug metabolism in the paediatric population and in the elderlyMargherita Strolin Benedetti, Rhys Whomsley, Michael Canning
Expert Opinion on Drug Metabolism & Toxicology|November 28, 2006
Involvement of enzymes other than CYPs in the oxidative metabolism of xenobioticsMargherita Strolin Benedetti, Rhys Whomsley, Eugène Baltes
Clinical Pharmacology and Therapeutics|December 21, 2006
Comment on severe arrhythmia as a result of the interaction of cetirizine and pilsicainide in a patient with renal insufficiencyRhys Whomsley, Margherita Strolin-Benedetti, Eugène Baltes
British Journal of Clinical Pharmacology|February 18, 2021
Environmental risk assessment of advanced therapies containing genetically modified organisms in the EURhys Whomsley, Victoria Palmi Reig, Ana Hidalgo-Simon
Fundamental & Clinical Pharmacology|September 18, 2007
Amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans: has the involvement of amine oxidases been neglected?Margherita Strolin Benedetti, Keith F Tipton, Rhys Whomsley
European Journal of Clinical Pharmacology|October 8, 2003
Pharmacokinetics and metabolism of 14C-levetiracetam, a new antiepileptic agent, in healthy volunteersMargherita Strolin Benedetti, Rhys Whomsley, Jean-Marie Nicolas, et al.
Regulatory Toxicology and Pharmacology : RTP|January 22, 2026
Nitrosamine Drug Substance-Related Impurities cause DNA methylation adducts in vitro and in primary hepatocytes upon Cytochrome P450-dependend metabolic activationMatthias Vogel, Max J Carlsson, Claudia Skowron, et al.
Drug Testing and Analysis|March 13, 2025
Quantitative Investigation of Nitrosamine Drug Substance-Related Impurities (NDSRIs) Under Artificial Gastric Conditions by Liquid Chromatography-Tandem Mass Spectrometry and Structure-Activity Relationship AnalysisMatthias Vogel, Sylvia E Escher, Emanuel Weiler, et al.
Drug Metabolism Reviews|July 16, 2009
Drug interactionsAlan Boobis, Jean-Baptiste Watelet, Rhys Whomsley, et al.
Drug Metabolism Reviews|July 16, 2009
Pharmacokinetics in special populationsItalo Poggesi, Margherita Strolin Benedetti, Rhys Whomsley, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Drug Discovery Today|August 21, 2007
Drug metabolism in the paediatric population and in the elderlyMargherita Strolin Benedetti, Rhys Whomsley, Michael Canning
Expert Opinion on Drug Metabolism & Toxicology|November 28, 2006
Involvement of enzymes other than CYPs in the oxidative metabolism of xenobioticsMargherita Strolin Benedetti, Rhys Whomsley, Eugène Baltes
Clinical Pharmacology and Therapeutics|December 21, 2006
Comment on severe arrhythmia as a result of the interaction of cetirizine and pilsicainide in a patient with renal insufficiencyRhys Whomsley, Margherita Strolin-Benedetti, Eugène Baltes
British Journal of Clinical Pharmacology|February 18, 2021
Environmental risk assessment of advanced therapies containing genetically modified organisms in the EURhys Whomsley, Victoria Palmi Reig, Ana Hidalgo-Simon
Fundamental & Clinical Pharmacology|September 18, 2007
Amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans: has the involvement of amine oxidases been neglected?Margherita Strolin Benedetti, Keith F Tipton, Rhys Whomsley
European Journal of Clinical Pharmacology|October 8, 2003
Pharmacokinetics and metabolism of 14C-levetiracetam, a new antiepileptic agent, in healthy volunteersMargherita Strolin Benedetti, Rhys Whomsley, Jean-Marie Nicolas, et al.
Regulatory Toxicology and Pharmacology : RTP|January 22, 2026
Nitrosamine Drug Substance-Related Impurities cause DNA methylation adducts in vitro and in primary hepatocytes upon Cytochrome P450-dependend metabolic activationMatthias Vogel, Max J Carlsson, Claudia Skowron, et al.
Drug Testing and Analysis|March 13, 2025
Quantitative Investigation of Nitrosamine Drug Substance-Related Impurities (NDSRIs) Under Artificial Gastric Conditions by Liquid Chromatography-Tandem Mass Spectrometry and Structure-Activity Relationship AnalysisMatthias Vogel, Sylvia E Escher, Emanuel Weiler, et al.
Drug Metabolism Reviews|July 16, 2009
Drug interactionsAlan Boobis, Jean-Baptiste Watelet, Rhys Whomsley, et al.
Drug Metabolism Reviews|July 16, 2009
Pharmacokinetics in special populationsItalo Poggesi, Margherita Strolin Benedetti, Rhys Whomsley, et al.
Pageof 3